The stock of Applied Therapeutics Inc. (NASDAQ:APLT) decreased by -$0.06 on Friday to finish at $1.51, down -3.82 percent. The last five days have seen an average of 350,280 shares of common stock traded. 11 times new highs were reached in the current year, with a gain of $0.7500. The average number of shares traded over the last 20 days was 405,700, while the average volume over the last 50 days totaled 258,796.
APLT stock appreciated 9.42% since last month. On 07/21/23, the company’s shares reached a one-month low of $1.3400. The stock touched a high of $2.18 on 05/01/23, after rallying from a low of $0.50 in 52 weeks. The price of APLT stock has risen by 98.68% or $0.7500 this year, reaching a new high 11 times. Still, the stock price is down -30.73% from the 52-week high.
Insider Transactions
APLT stock investors should be aware that Applied Therapeutics Inc. (APLT) stock had its last reported insider trading activity 215 days ago on Jan 11. On Jan 11, President and CEO Shendelman Shoshana sold 15,870 shares at $0.91 each. This transaction resulted in the insider making $14,442. On Jan 11, Perfetti Riccardo sold 6,053 shares at a price of US$0.91. After the transaction, the insider now owns 154,856 shares. Chief Commercial Officer Hansard Adam had earlier sold 4,495 shares on Jan 11 for $0.91 a share. The transaction was completed for $4,090.
Financial Health
For the recent quarter, Applied Therapeutics Inc.’s quick ratio was 0.90, while its current ratio was 0.90, indicating its inability to pay off its debt.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. APLT’s return on assets (ROA) during the last 12 months has been -162.40%. In the meantime, the return on equity (ROE) for the last 12 months was -931.60%.
Earnings Surprise
EBITDA was -$16.49 million for the quarter. At the end of Applied Therapeutics Inc.’s most recent quarter, its liabilities totaled 47.98 million, while its total debt was $1.9 million. Equity owned by shareholders amounts to $63.12 million.
Technical Picture
Here’s a quick look at Applied Therapeutics Inc.’s (APLT) price momentum from a technical perspective. As of 11 August, the RSI 9-day stood at 44.00%, suggesting the stock is Neutral, with a 88.77% historical volatility rate.
The stochastic %K and %D were 20.92% and 24.47% respectively, while the average true range (ATR) was 0.1830. Based on the 14-day stochastic reading of 12.70%, the RSI (14) reading is 48.13%. On the 9-day MACD Oscillator, the stock is at -0.1222, and the 14-day reading is at -0.0826.
Analyst Ratings
Applied Therapeutics Inc. (NASDAQ: APLT) was downgraded by Barclays to a an Equal weight rating in its latest research report. The stock was previously rated as a an Overweight. Analysts have assigned Applied Therapeutics Inc. (APLT) an Overweight rating. APLT is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 1 other recommend it as a buy.
What is APLT’s price target for the next 12 months?
The current consensus forecast for the stock is between $5.00 and $14.00, with a median target price of $9.50. In analyzing these forecasts, the average price target given by analysts for Applied Therapeutics Inc. (APLT) is $9.50.
